New SARS-CoV-2 Antibody Test Determines Previous Covid-19 Infection in 1.5 Hours
The Randox SARS-CoV-2 IgG (RBD & NP) Array offers clinicians an opportunity to discriminate vaccinated individuals from those naturally infected by covid-19.
Read MorePosted by Laurie Bonner | Dec 23, 2020 | Covid 19, Immunoassay Reagents & test Kits |
The Randox SARS-CoV-2 IgG (RBD & NP) Array offers clinicians an opportunity to discriminate vaccinated individuals from those naturally infected by covid-19.
Read MorePosted by Melanie Hamilton-Basich | Dec 22, 2020 | Covid 19, Research |
Under certain conditions, self-collected swabs may be a good alternative to nasopharyngeal swabs collected by health professionals for antigen testing.
Read MorePosted by Melanie Hamilton-Basich | Dec 22, 2020 | Covid 19 |
HHS plans to provide weekly shipments of SARS-CoV-2 sample collection supplies to states and territories through at least March 2021.
Read MorePosted by Laurie Bonner | Dec 22, 2020 | Covid 19, Immunoassay Reagents & test Kits |
Genscript’s test is capable of detecting virus-blocking antibodies that can be performed in standard labs in under an hour.
Read MorePosted by Melanie Hamilton-Basich | Dec 21, 2020 | Covid 19 |
The IFCC Global Conference on Covid-19 will take place virtually February 15-17, 2021, with the theme “Critical Role of Clinical Laboratories in the Covid-19 Pandemic.”
Read More